Home › Atopic Dermatitis (Eczema) › Florida
Atopic Dermatitis (Eczema) clinical trials in Florida
19 studies for Atopic Dermatitis (Eczema) are looking for participants at sites in Florida.
Cities in Florida
- Miami11 studies
- Tampa6 studies
- Coral Springs3 studies
- Jacksonville3 studies
- Miami Gardens3 studies
- St. Petersburg3 studies
- Boca Raton3 studies
A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to-Severe Eczema
- Pediatric Skin Research, Miami
- AllerVie Clinical Research, Panama City
- GCP Research , Global Clinical Professionals, St. Petersburg
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Nov 12, 2026 · NCT07765888Evaluation of a Non-Invasive Device for Early Detection of Atopic Dermatitis Flares
- True Blue Clinical Research, Tampa
RecruitingObservational study
Ages 12 to 89 · All sexes · Updated Nov 9, 2026 · NCT07645820A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis
- Leo Pharma Investigational site, Jacksonville
- Leo Pharma Investigational site, Miami
- Leo Pharma Investigational site, Tampa
RecruitingPhase 3
6 Months – 11 Years · All sexes · Updated Nov 9, 2026 · NCT06311682First-in-Human Trial to Assess REGN20423 in Healthy Adult Participants and Adult Participants With Atopic Dermatitis
- Florida International Research Center, Miami
- Encore Medical Research of Weston LLC, Weston
RecruitingPhase 1Healthy volunteers welcome
Ages 18 to 65 · All sexes · Updated Nov 6, 2026 · NCT07527923Roflumilast Cream 0.3% for Moderate to Severe Atopic Dermatitis
- Arcutis Site 321, Miami Lakes
RecruitingPhase 3
Ages 6 and older · All sexes · Updated Nov 6, 2026 · NCT07916480A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to Severe Eczema
- Direct Helpers Research Center, Hialeah
- Research Associates of South Florida, LLC, Miami
- Global Health Research Center, Inc., Miami Lakes
- and 2 more
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Nov 6, 2026 · NCT07783425A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema
- Solutions Through Advanced Research, Jacksonville
RecruitingPhase 3
Ages 2 to 11 · All sexes · Updated Nov 5, 2026 · NCT06807281FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients
- Miami Dermatology and Laser Research, Miami
RecruitingPhase 1Healthy volunteers welcome
Ages 18 to 70 · All sexes · Updated Nov 5, 2026 · NCT06564389A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema
- Gsi Clinical Research, Margate
RecruitingPhase 2
Ages 18 to 64 · All sexes · Updated Nov 5, 2026 · NCT07216027A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis
- Investigational Site, Coral Gables
- Investigational Site, Jacksonville
- Investigational Site, Margate
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 3, 2026 · NCT07003425This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
- St. Jude Clinical Research- Site Number : 8400049, Doral
- Ziaderm Research, LLC- Site Number : 8400021, North Miami Beach
RecruitingObservational study
Ages 12 and older · All sexes · Updated Nov 2, 2026 · NCT07290803A Study Evaluating TRIV-573 in Atopic Dermatitis
- Triveni Bio Site #11, Boca Raton
- Triveni Bio Site #7, Miami
- Triveni Bio Site #3, Miami
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Oct 28, 2026 · NCT07782333Ph 1a/1b Single Ascending Dose and Multiple Ascending Dose Study of ARQ-234
- Clinical Site 112, Miami
- Clinical Site 110, Miami
RecruitingPhase 1Healthy volunteers welcome
Ages 18 to 65 · All sexes · Updated Oct 23, 2026 · NCT07453602Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
- Novartis Investigative Site, Miami
- Novartis Investigative Site, St. Petersburg
RecruitingPhase 2
Ages 18 to 100 · All sexes · Updated Sep 28, 2026 · NCT06947993Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
- Enveda Investigative Site, Fort Lauderdale
- Enveda Investigative Site, Miami
- Enveda Investigative Site, Miramar
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Sep 25, 2026 · NCT07298395A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
- ABMED Clinical Research Corp., Cape Coral
- Skin Care Research, Hollywood
- Quality Care Clinical Research, Miami
- and 4 more
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Aug 28, 2026 · NCT07599813A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
- Inmagene Site 19, Ocala
- Inmagene Site 4, Tampa
RecruitingPhase 2
Ages 18 to 74 · All sexes · Updated Aug 12, 2026 · NCT07037901A Phase 2b Dose-Ranging Study to Evaluate the Efficacy and Safety of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
- Enveda Investigative Site, Boca Raton
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Aug 6, 2026 · NCT07643766Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
- Galderma Investigational Site 8597, Boca Raton
- Galderma Investigational Site 7087, Coral Gables
- Galderma Investigational Site 7063, Cutler Bay
- and 7 more
RecruitingObservational study
Ages 12 and older · All sexes · Updated Mar 13, 2026 · NCT06988605From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.